Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Clinical trial of curcumin in people with cystic fibrosis

Clinical trial of curcumin in people with cystic fibrosis

Scientists have discovered an exciting new target in the fight to stop the spread of cancer cells

Scientists have discovered an exciting new target in the fight to stop the spread of cancer cells

Researchers use IBM Linux supercomputing cluster to research DNA

Researchers use IBM Linux supercomputing cluster to research DNA

Functional genomics provide improved drug discovery

Functional genomics provide improved drug discovery

Australian company set to spearhead drug discovery

Australian company set to spearhead drug discovery

World's largest drug-like library comprising 100 million diverse compounds synthesised in a single test tube

World's largest drug-like library comprising 100 million diverse compounds synthesised in a single test tube

Researchers find drug that may suppress genetic mutation using a novel screening approach

Researchers find drug that may suppress genetic mutation using a novel screening approach

New process to extract proteins from membranes by using chemicals

New process to extract proteins from membranes by using chemicals

The Cambridge-MIT Institute has launched a project to tackle the bottlenecks that slow development of new drugs

The Cambridge-MIT Institute has launched a project to tackle the bottlenecks that slow development of new drugs

Pharmacopeia announces that proposed spin-off of Pharmacopeia Drug Discovery, Inc. unit is expected to occur by the end of April 2004

Pharmacopeia announces that proposed spin-off of Pharmacopeia Drug Discovery, Inc. unit is expected to occur by the end of April 2004

Phase 3 study of drug teduglutide in patients with short bowel syndrome

Phase 3 study of drug teduglutide in patients with short bowel syndrome

Collaboration to create a series of small molecule drugs leads against a Takeda target

Collaboration to create a series of small molecule drugs leads against a Takeda target

A simple urine sample could soon be used to predict the complex toxic effects of new drugs

A simple urine sample could soon be used to predict the complex toxic effects of new drugs

New software promises to speed drug development

New software promises to speed drug development

GlaxoSmithKline and Theravance to form strategic alliance

GlaxoSmithKline and Theravance to form strategic alliance

World’s largest biotechnology company acquires Tularik

World’s largest biotechnology company acquires Tularik

New Australian collaboration to discover new drugs targeting epilepsy and anxiety

New Australian collaboration to discover new drugs targeting epilepsy and anxiety

Air pollution effects Cystic Fibrosis Sufferers

Air pollution effects Cystic Fibrosis Sufferers

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

Joint Research Collaboration to Predict 3-D Protein Structures and Support Drug Discovery

Joint Research Collaboration to Predict 3-D Protein Structures and Support Drug Discovery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.